BeOne Medicines AG
BEIGF
$21.95
-$0.56-2.48%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 151.28% | 17,802.13% | 143.79% | 202.88% | 178.34% |
| Total Depreciation and Amortization | 30.33% | 24.57% | -29.81% | -49.01% | 25.73% |
| Total Amortization of Deferred Charges | -72.31% | 48.51% | 30.60% | 29.60% | 388.45% |
| Total Other Non-Cash Items | -9.95% | 38.56% | -22.67% | 30.06% | 13.25% |
| Change in Net Operating Assets | 1,202.99% | -142.41% | 967.10% | -23.34% | 104.72% |
| Cash from Operations | 75.58% | 356.73% | 455.28% | 113.70% | 375.76% |
| Capital Expenditure | 37.31% | 27.69% | 59.43% | 64.02% | 60.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.96% | 92.80% | 27.73% | -424.23% | -2,005.27% |
| Cash from Investing | 25.90% | 62.68% | 59.05% | 63.20% | 40.01% |
| Total Debt Issued | -100.00% | -27.25% | 58.63% | -- | -22.40% |
| Total Debt Repaid | 85.23% | 95.69% | -40.64% | -19.71% | 31.25% |
| Issuance of Common Stock | -66.67% | -62.32% | 118.79% | 396.42% | 495.69% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -117.28% | 303.19% | 2,243.07% | 7,491.79% | 52.17% |
| Foreign Exchange rate Adjustments | -15.51% | 455.17% | 144.79% | -65.06% | 497.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.22% | 325.39% | 768.32% | 1,286.91% | 234.82% |